Citadel Advisors’s MiNK Therapeutics INKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,081
Closed -$18.9K 6353
2024
Q1
$18.9K Sell
2,081
-2,133
-51% -$19.4K ﹤0.01% 5560
2023
Q4
$45.3K Buy
+4,214
New +$45.3K ﹤0.01% 5156
2023
Q3
Sell
-5,105
Closed -$107K 6165
2023
Q2
$107K Buy
+5,105
New +$107K ﹤0.01% 4716